Cargando…
Predicting HIV Pre-exposure Prophylaxis Efficacy for Women using a Preclinical Pharmacokinetic-Pharmacodynamic In Vivo Model
The efficacy of HIV pre-exposure prophylaxis (PrEP) relies on adherence and may also depend on the route of HIV acquisition. Clinical studies of systemic tenofovir disoproxil fumarate (TDF) PrEP revealed reduced efficacy in women compared to men with similar degrees of adherence. To select the most...
Autores principales: | Wahl, Angela, Ho, Phong T., Denton, Paul W., Garrett, Katy L., Hudgens, Michael G., Swartz, Glenn, O’Neill, Cynthia, Veronese, Fulvia, Kashuba, Angela D., Garcia, J. Victor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5286499/ https://www.ncbi.nlm.nih.gov/pubmed/28145472 http://dx.doi.org/10.1038/srep41098 |
Ejemplares similares
-
Editorial: Pharmacokinetics and Pharmacodynamics of Pre-Exposure Prophylaxis Against HIV
por: von Kleist, Max, et al.
Publicado: (2020) -
Preclinical Pharmacokinetics, Pharmacodynamics and Safety of Sucroferric
Oxyhydroxide
por: Cozzolino, Mario, et al.
Publicado: (2014) -
Preclinical pharmacodynamic and pharmacokinetic characterization of the major metabolites of cariprazine
por: Kiss, Béla, et al.
Publicado: (2019) -
Pharmacokinetic/Pharmacodynamic
Determination and Preclinical Pharmacokinetics of the β-Lactamase
Inhibitor ETX1317 and Its Orally Available Prodrug ETX0282
por: O’Donnell, John, et al.
Publicado: (2020) -
Pharmacokinetic/pharmacodynamic investigation of raltegravir with or without lamivudine in the context of HIV-1 pre-exposure prophylaxis (PrEP)
por: Herrera, Carolina, et al.
Publicado: (2021)